Clinical research on COVID- 19. A Brief Overview

Authors

Keywords:

coronavirus infection, SARS-CoV-2, COVID-19, pandemic, Clinical Trials, Cuba

Abstract

Since its inception, scientists around the world have worked tirelessly in the development of new therapeutic alternatives that promote the prevention and treatment of COVID-19. The historical-logical method was used, with the support of the document review technique in the period from March to August 2020. The information collected from clinical investigations registered in the clinicaltrials.gov database was reviewed; also the website of the World Health Organization (WHO) and the Cuban public registry of clinical trials. Research is currently being carried out and registered in the international clinicallatrials.gov database related to therapeutic alternatives for COVID-19. 3015 investigations from 115 countries were registered until August 25, 2020. Of these, 53 investigations are observational and 698 are interventional studies (11 of these are investigations of expanded clinical use and the rest are clinical trials). 402 research products are under study. Twenty-one investigations, 5 observational ones and 16 clinical trials have been registered in Cuba, and the emerging use of CIGB 258, Jusvinza, and the nasopharyngeal swab as health technology.

Downloads

Download data is not yet available.

Author Biographies

Tatiana Marañón Cardonne, Hospital General Dr. Juan Bruno Zayas Alfonso

Especialista en Ginecología y Obstetricia. Secretaria Consejo Científico Institucional

Coordinadora de la investigación Clínica

Responsable del Sistema de Ciencia e Innovación Tecnológica

Departamento Docencia e Investigación

Dianne Yurien Griñan Semanat, Centro nacional Coordinador de Ensayos Clínicos

Coordinadora provincial de ensayos clínicos

Sanlia Landazuri Llago, Centro nacional Coordinador de Ensayos Clínicos

Coordinadora provincial de ensayos clínicos

Enrique Juan Marañón Reyes, Universidad de Oriente

Profesor Titular, Académico de Honor d ela Academia de Ciencias de Cuba

Downloads

Published

2020-10-05

How to Cite

Marañón Cardonne, T., Griñan Semanat, D. Y., Landazuri Llago, S., & Marañón Reyes, E. J. (2020). Clinical research on COVID- 19. A Brief Overview. Anales De La Academia De Ciencias De Cuba, 10(3), e910. Retrieved from https://revistaccuba.sld.cu/index.php/revacc/article/view/910

Issue

Vol. 10 No. 3 (2020): septiembre-diciembre

Section

Biomedical sciences

License

The journal Anales de la Academia de Ciencias de Cuba protects copyright, and operates with a Creative Commons License 4.0 (Creative Commons Attribution-NonCommercial License 4.0). By publishing in it, authors allow themselves to copy, reproduce, distribute, publicly communicate their work and generate derivative works, as long as the original author is cited and acknowledged. They do not allow, however, the use of the original work for commercial or lucrative purposes.

The authors authorize the publication of their writings, retaining the authorship rights, and assigning and transferring to the magazine all the rights protected by the intellectual property laws that govern in Cuba, which imply editing to disseminate the work.

Authors may establish additional agreements for the non-exclusive distribution of the version of the work published in the journal (for example, placing it in an institutional repository or publishing it in a book), with recognition of having been first published in this journal.

To learn more, see https://creativecommons.org